Status:
COMPLETED
Bp-MRI Based Multi-planar VI-RADS
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Bladder (Urothelial, Transitional Cell) Cancer
MRI
Eligibility:
All Genders
18-90 years
Brief Summary
This study is a prospective, single-center, observational clinical trial, enrolling 100 patients with malignant bladder tumors admitted to the Department of Urology at the People's Hospital of Jiangsu...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Patients with indications of bladder cancer from preoperative assessments;
- Unrestricted by gender;
- Age of 18 years or older;
- Absence of contraindications for Magnetic Resonance Imaging (MRI);
- Provision of informed consent for the use of personal clinical data, pathology, and imaging for research purposes.
- Exclusion Criteria
- Time lapse exceeding one month between multiplanar Bp-MRI examination and surgical intervention;
- Compromised MRI image quality due to significant artifacts, inadequate bladder filling, or absence of identifiable lesions within the bladder;
- Postoperative histopathology confirming non-urothelial bladder cancer;
- Inability to undergo surgery due to severe medical conditions, including heart failure, acute myocardial infarction, and severe cardiac or pulmonary diseases, rendering the patient unable to withstand routine surgical procedures;
- Recent surgical procedures (e.g., Transurethral Resection of Bladder Tumor, TURBT) prior to MRI examination;
- Any conditions identified by investigators that could potentially harm subjects or impede their ability to meet the study requirements;
- Inability to provide written informed consent for participation.
Exclusion
Key Trial Info
Start Date :
February 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2024
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT06607250
Start Date
February 20 2023
End Date
February 1 2024
Last Update
September 23 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210009